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in the organization of the muscle postsynaptic machinery. 
Overexpression of the H246R MVI mutant (associated with 
hypertrophic cardiomyopathy) in myoblasts and NRCs 
caused the formation of abnormally large intracellular vesi-
cles. MVI knockdown caused changes in myoblast mor-
phology and inhibition of their migration. On the subcellu-
lar level, MVI-depleted myoblasts exhibited aberrations in 
the organization of actin cytoskeleton and adhesive struc-
tures as well as in integrity of Golgi apparatus and endo-
plasmic reticulum. Also, MVI depletion or overexpression 
of H246R mutant caused the formation of significantly 
wider or aberrant myotubes, respectively, indicative of 
involvement of MVI in myoblast differentiation. The pre-
sented results suggest an important role for MVI in myo-
genic cells and possibly in myoblast differentiation.
Keywords Actin cytoskeleton · Adhesion · 
Cardiomyocytes · Cell migration · Differentiation · 
Endoplasmic reticulum · Golgi apparatus ·  
Neuromuscular junction · Talin
Introduction
Myosins form a structurally and functionally diverse super-
family of actin-based molecular motors expressed in all 
eukaryotic cells that consists of more than 35 distinct fami-
lies (Odronitz and Kollmar 2007). Besides the nomencla-
ture based on family affiliation, myosins are also termed 
as conventional (i.e., belonging to class II muscle and non-
muscle myosins able to form filaments) or unconventional 
(all the remaining families).
So far, myosin I isoforms, IA, IB, and IC; myosin VA; 
myosin VIIA; myosins IXA and IXB as well as myosins 
XVIIIA and B were identified in striated muscle and/or in 
Abstract The important role of unconventional myosin 
VI (MVI) in skeletal and cardiac muscle has been recently 
postulated (Karolczak et al. in Histochem Cell Biol 
139:873–885, 2013). Here, we addressed for the first time 
a role for this unique myosin motor in myogenic cells as 
well as during their differentiation into myotubes. During 
myoblast differentiation, the isoform expression pattern of 
MVI and its subcellular localization underwent changes. In 
undifferentiated myoblasts, MVI-stained puncti were seen 
throughout the cytoplasm and were in close proximity to 
actin filaments, Golgi apparatus, vinculin-, and talin-rich 
focal adhesion as well as endoplasmic reticulum. Colocali-
zation of MVI with endoplasmic reticulum was enhanced 
during myotube formation, and differentiation-dependent 
association was also seen in sarcoplasmic reticulum of neo-
natal rat cardiomyocytes (NRCs). Moreover, we observed 
enrichment of MVI in myotube regions containing acetyl-
choline receptor-rich clusters, suggesting its involvement 
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myogenic cells, and shown to be potentially involved in 
differentiation of myoblasts into myotubes, and in muscle 
development and/or regeneration (Wells et al. 1997; Salamon 
et al. 2003; Redowicz 2007; Roder et al. 2012; Cao et al. 
2014; Sun et al. 2014). Specifically, myosin XVIIIB plays 
a key role in cardiac muscle development and is involved 
in Drosophila myoblast fusion, and PDZ-containing myo-
sin XVIIIA isoform has been recently found in zebrafish 
to maintain the stable attachment of myofibers to extracel-
lular matrix and muscle integrity during early development 
(Ajima et al. 2008; Bonn et al. 2013; Cao et al. 2014).
Recently, we have shown that myosin VI (MVI) 
is expressed in striated muscles, where it seems to be 
involved in the function of the sarcoplasmic reticulum and 
neuromuscular junction, and possibly in gene transcription 
(Karolczak et al. 2013, 2014). Notably, its amount was sig-
nificantly increased in atrophic fibers of muscle biopsies 
obtained from patients with several myopathies (Karolczak 
et al. 2014). In humans, a point mutation (H246R) within 
the MVI gene was associated with cardiac hypertrophy, 
suggesting an important role of this molecular motor in 
striated muscles (Mohiddin et al. 2004).
The MVI heavy chain (MW ~140 kDa) has a domain 
pattern characteristic for all the myosins. It has (i) an 
N-terminal motor domain (with the actin- and ATP-binding 
sites); (ii) a neck, which binds two calmodulin molecules; 
and (iii) a tail domain, with C-terminal part forming a 
globular domain involved in cargo binding and/or interac-
tion with its partners (Fig. 1a; Tumbarello et al. 2013). Four 
splice variants of MVI can be formed in mammalian cells 
due to the presence of two inserts (small and large) within 
the tail domain (Fig. 1a; Aschenbrenner et al. 2003; Au 
et al. 2007). These authors postulate that the inserts could 
determine MVI subcellular localization and thus function.
MVI functions through its interaction with actin (via 
the N-terminal motor domain) and partner proteins (via 
the C-terminal cargo domain). Two tail regions were found 
to be involved in binding partner recognition: a positively 
charged RRL region and a hydrophobic WWY region 
(Tumbarello et al. 2013). Also, a positively charged clus-
ter of the MVI C-terminal globular tail was shown to bind 
to PIP2-containing liposomes, possibly aiding in the bind-
ing partners recognition (Spudich et al. 2007). It has been 
recently shown that MVI must dimerize and deploy its 
unusual lever arm in order to perform its cellular functions 
(Mukherjea et al. 2014).
Numerous tissue- and cell-specific MVI-binding part-
ners have been already identified in mammals; among them 
are adaptor proteins, enzymes, and proteins involved in the 
regulation of cytoskeleton dynamics (Tumbarello et al. 2013; 
Majewski et al. 2012). We have recently shown that in skel-
etal muscle, MVI seems to interact with TOM1 (target of 
myb1 homolog isoform 1), a protein involved in intracellular 
transport and autophagy, FMRP (fragile X mental retarda-
tion protein involved in mRNA transport) as well as with 
hnRNP proteins, heterogeneous ribonucleoproteins involved 
in the RNA transport and maturation (Karolczak et al. 2013).
Unlike other known myosins, MVI moves backward 
(i.e., toward the minus, pointed end of actin filaments), 
implying that it has a role distinct from other myosins 
(Wells et al. 1999). It has been reported that MVI is 
involved in endocytosis and intracellular transport of vesi-
cles and organelles, cell migration, maintenance of Golgi 
apparatus, actin cytoskeleton organization, and possibly in 
gene transcription (Jung et al. 2006; Vreugde et al. 2006; 
Sweeney and Houdusse 2007, 2010; Chibalina et al. 2009; 
Majewski et al. 2011).
Although unconventional myosins could be involved 
in muscle precursor function (Redowicz 2007), no studies 
have been published to date on the role of MVI in myo-
genic cells and their differentiation. Here, we present for 
the first time the data, indicating that in myogenic cells, 
MVI plays an important role in myoblast function and their 
differentiation into the myotube by regulating the organiza-
tion of the actin cytoskeleton, maintenance of endoplasmic 
reticulum and Golgi apparatus, and the formation of cell 
adhesions and muscle postsynaptic machinery.
Materials and methods
Cell culture
C2C12 mouse myoblasts (American Type Culture Collec-
tion, USA), kindly provided by Prof. Krzysztof Zablocki 
from the Nencki Institute, were maintained in DMEM con-
taining 4.5 g/l glucose and supplemented with 10 % heat-
inactivated fetal bovine serum (FBS), antibiotics (1000 UI/
ml penicillin and 1000 UI/ml), and 4 mM l-glutamine at 
37 °C in humidified air containing 5 % CO2. Differentiation 
was initiated upon reaching confluence (considered as day 
0) by transferring to medium containing 2 % horse serum 
(HS) instead of 10 % FBS, and the culture was continued 
for up to next 7–10 days. To observe postsynaptic structures, 
cells were differentiated in 8-well Permanox chamber slides 
(Sigma-Aldrich, USA) coated with laminin (Invitrogen, 
USA) as described by Proszynski et al. (2009). The differen-
tiation was monitored with the Nikon inverted microscope 
equipped with a Nikon PLAN 10DIC/0.25 long-working-
distance objective. The images were collected using cooled 
CCD camera (Retiga 1300, QImaging Co., Canada),
Isolation and culture of neonatal rat cardiomyocytes
Newborn rat hearts were dissected and digested using 
the Neonatal Cardiomyocyte Isolation System from 
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Worthington (Worthington Biochemical Corp., USA) and 
cultured up to 8 days as described previously (Iskratsch 
et al. 2010). Housing and killing procedures were per-
formed in compliance with the European Communities 
Council Directive of November 24, 1986 (86/609/EEC).
Myosin VI splice variant analysis
RT-PCR was performed as described by Karolczak et al. 
(2013) using the following primers flanking the sequence of 
the small (forward: 5′-GCTCCCAAGTCGGTTACT-3′ and 
reverse: 5′-TTGTTCTGAGGGTCTTTGTA-3′) and large 
(forward 5′-GATGAGGCACAGGGTGAC-3′ and reverse 
5′-GCGTATTTCCATTTACTGAGA-3′) inserts of the 
mouse myosin VI gene as well as glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) gene as an internal control. 
PCR products were run on 3 % agarose gel. The location of 
the inserts and their sequence is depicted in Fig. 1a.
MVI overexpression
Plasmids encoding human MVI variants (gene ID 
Q9UM540), namely pEGFP-C3-MVI FL+S+ and pEGFP-
C3-MVI FL−S+ encoding the small insert-containing 
variants with and without large insert, respectively, were 
generously provided by Dr. Tama Hasson from University 
Fig. 1  MVI expression during differentiation. a Diagram represent-
ing the domain structure of MVI. Location of large and small inserts 
of the mouse MVI is indicated. b Phase-contrast images of C2C12 
myotubes after 3 (day-3) and 7 (day-7) days of differentiation. Day-0 
myoblasts shortly before switching to 2 % horse serum-containing 
medium. c Analysis of MVI, fast (MHCf) and slow (MHCs) myosin 
heavy chains as well as α-, β-, and γ-actin levels by immunoblot at 
indicated days after the initiation of differentiation. A representa-
tive immunoblot is shown. Right panel: a quantitative analysis of the 
MVI content during myoblast differentiation with respect to the level 
of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Values 
are means ± SD; ***p < 0.001, as measured by Student’s t test. d 
Assessment of MVI splice variant levels by RT-PCR in differentiating 
myoblasts. The products obtained with primers designed to produce 
fragments containing either small or large inserts, as indicated in the 
figure. e MVI and its splice variants distribution in undifferentiated 
myoblasts. The endogenous MVI localization was assessed with anti-
porcine MVI antibody (αMVI). Myoblasts were also transfected with 
GFP-tagged human MVI constructs encoding MVI variants with: 
both inserts (L+S+), the large insert (L+S−), the small insert (L−
S+), and without inserts (L−S−). A plasmid encoding GFP alone 
was used as control. Lower panels ×~3 magnification of the areas 
marked in the corresponding upper panels. Bars in (b, e), 100 and 
20 μm, respectively
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of California, Los Angeles (Dance et al. 2004). Plasmids 
containing the variant without the small insert (pEGFP-
C3-MVI FL+S−) and without any insert (pEGFP-C3-
MVI FL−S−) were generated in our laboratory using the 
following primers: forward 5′-CCTCAGCAAAACCC 
AGCAGCTCAGATTCCT-3′ and reverse 5′-ATAATCAGT 
AACAGACTTTGGAGCACGTTG-3′. Plasmid pEGFP-
C3-MVI FL+S+H/R encoding MVI with point mutation 
(His246Arg) was obtained using forward 5′-AAGAAA 
TTATAGGATCTTTTATAGGTTGTGT-3′ and reverse 5′-AC 
ACAACCTATAAAAGATCCTATAATTTCTT-3′ primers. 
C2C12 cells (untreated or treated with MVI knockdown) 
were next plated on coverslips in 35-mm dishes, cultured 
for 24 h, and transfected with the plasmids using Lipo-
fectamine 2000 (Invitrogen, USA) according to the manu-
facturer’s protocol. Plasmid pEGP-C3 was used as control.
siRNA knockdown of MVI
C2C12 cell line with MVI stable knockdown (MVI-
KD cell line) was generated based on pSilencer 2.1-U6 
hygro vector system (Ambion Inc., USA) essentially as 
described by Majewski et al. (2011). 5′-AACTACGCGAT 
ACAATCAATA-3′ siRNA sequence against a coding 
region of mouse MVI mRNA (gene ID Q64331) was used 
with the corresponding scrambled sequence as a nega-
tive control (5′-ATAACATACCGTACGAATAAC-3′). Of 
note, the chosen shRNA targeted the different MVI region 
than the ones used for the protein depletion in PC12 cells 
(Majewski et al. 2011). C2C12 cells were transfected 
using Lipofectamine 2000 and then selected on hygro-
mycin B (Sigma-Aldrich, USA). C2C12 cells were also 
transiently transfected with the pSuper vector containing 
siRNA sequence against a coding region of rat MVI (gene 
ID D4A5I9) mRNA (5′-CTTCGCGATACAATCAACA-3′, 
3395–3413—partially overlapping with the sequence used 
for obtaining the stable MVI knockdown cells) and pSuper 
vector with a scrambled MVI sequence as control on day 
1 (i.e., 1 day after transferring to the differentiating condi-
tions), and then, cells were differentiated for next 6 days. 
The differentiation was monitored as described above. MVI 
expression level was assessed by the Western blot as well 
as RT-PCR.
Antibodies and fluorescent markers
Rabbit polyclonal antibody directed against the amino acid 
residues 1049–1054 of the porcine myosin VI heavy chain 
was purchased from Proteus (USA), and anti-β-actin was 
commercially generated for us by EZBiolab (USA). Goat 
polyclonal antibody against human calreticulin was a gift 
from Dr. Marek Michalak from the University of Alberta 
(Canada). Sheep polyclonal antibody against γ-actin was 
from Merck Millipore (USA). The following monoclo-
nal antibodies were also used: anti-α-actinin and anti-β-
actin from Sigma-Aldrich (Germany), anti-α-actin and 
anti-GRP78 from Abcam (UK), anti-GAPDH (glyceralde-
hyde 3-phosphodehydrogenase) and anti-SERCA 2 from 
Merck Millipore (USA), anti-GM130 from BD Biosciences 
(USA), as well as anti-fast and slow myosin heavy chains 
were from Abcam, anti-talin was from Santa Cruz Bio-
technology (USA), and anti-vinculin from Sigma-Aldrich 
(USA). TO-PRO®-3 iodide staining chromatin, Alexa Flour 
488-conjugated bungarotoxin staining muscle synapses, 
and Alexa Flour 546(or 488)-conjugated phalloidin were 
purchased from Invitrogen (USA).
Immunoblotting
Cells were lysed in an ice-cold buffer containing 50 mM 
Tris–HCl, pH 7.5; 150 mM NaCl; 0.1 % Triton X-100; 
1 mM DTT; 1 mM EGTA; 1 mM PMSF; and complete pro-
tease inhibitor cocktail (Roche). Cell lysates (10–20 μg of 
protein per well) were separated using 10 or 12 % SDS–
PAGE gels and then transferred to a nitrocellulose mem-
brane. Western blot was performed as described by Karol-
czak et al. (2013), and the bands were detected by the 
enhanced chemiluminescence technique (ECL) based on 
the activity of horse radish peroxidase conjugated with sec-
ondary antibodies. The blots were subjected to densitomet-
ric analysis, and Student’s t test was used to evaluate the 
quantitative data from at least three analyses of the lysates 
from independent experiments.
Immunolocalization studies
Cells on coverslips were fixed in 4 % formaldehyde in 
phosphate-buffered saline, pH 7.4 (PBS), for 20 min at 
room temperature, washed with PBS, blocked in 2 % horse 
serum, and permeabilized with 0.02 % Triton X-100 in 
PBS for 30 min at room temperature. Coverslips were then 
incubated for 2 h at room temperature or overnight at 4 °C 
with anti-MVI rabbit polyclonal antibody diluted 1:50 and 
cell compartment markers: sarcoplasmic reticulum: anti-
calreticulin (1:50), anti-GRP78 (1:500), and anti-SERCA2 
antibodies (1:50); Golgi apparatus: anti-GM130 (1:100); 
adhesive structures: anti-vinculin (1:50) and anti-talin 
(1:50); or the cytoskeleton: anti-α-actinin, anti-γ-actin, or 
anti-β-actin (all at 1:1000 dilution), washed with PBS, fol-
lowed by incubation with 1 µg/ml Alexa Fluor 488-conju-
gated goat anti-rabbit IgG or Alexa Fluor 546-conjugated 
goat anti-mouse, donkey anti-goat, or donkey anti-sheep 
IgG (Molecular Probes, Invitrogen). Vectashield mounting 
medium (Vector Laboratories, USA) was used to mount the 
slides. All fluorescence images were acquired on Leica TCS 
SP5 o SP8 confocal laser scanning microscope equipped 
25Histochem Cell Biol (2015) 144:21–38 
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with a HCX PL APO 40×/1.25–0.75 Oil Cs or HCX PL 
APO 63/1.4 Oil objective. An argon laser at 488 nm, a 
diode-pumped solid-state laser 561 nm, and a helium neon 
laser at 594 nm were used to excite Alexa Flour 488, 555, 
and 546 fluorescence, respectively. Optical sections (1024 
pixels × 1024 pixels × 12 bits/pixel) were collected usu-
ally at 0.30 µm z-spacing. In double or triple immunostain-
ing, special care was taken to control for any possible 
cross talk of the detection systems. The spectral ranges of 
the detectors were carefully adjusted for the detectors, and 
the different channels were always scanned sequentially. 
For negative controls, the primary antibody was omitted. 
Confocal sequences were further processed by lens point-
spread function deconvolution using Huygens Professional 
64 version 14.06 (Scientific Volume Imaging BV, the Neth-
erlands) software. Point-spread functions were calculated 
according to profiles of known Leica lens parameters, not 
measured. Synthetic imaging (Z stack reconstructions and 
multichannel image creation) was performed in the Fiji dis-
tribution of ImageJ software.
Analysis of cell shape
The analysis of shape of the examined cells was performed 
in the ImageJ software using the edge detection func-
tion based on the cell outlines. Circularity (defined as: 
4π × area/perimeter2) and roundness (defined as aspect 
ratio of the minor/major axis) parameters were calculated; 
for both, 1.0 indicated a perfect circle, and smaller values 
indicated oblong and non-circular objects. The analyses 
were done for at least 100 cells of each examined condition 
for at least two independent experiments.
Cell compartment analysis
MetaMorph software (Molecular Devices, USA, distributed 
as Leica MM AF version 1.4.0) was used for the quantifi-
cation studies. Golgi apparatus and endoplasmic reticulum 
areas were calculated after outlining their surface based on 
the staining for GM130 and calreticulin, respectively. The 
entire cell area was assessed after outlining the cell contours 
based on the Alexa Flour 546-phalloidin staining. At least 80 
images of cell centers from each experimental condition from 
two independent experiments were analyzed. Assessment of 
the size of focal adhesions was based on the number of vincu-
lin-stained pixels and performed in at least 20 cells from each 
experimental condition from two independent experiments. 
Statistical analysis was performed using Student’s t test.
Proximity ligation assay (PLA)
The assay was performed according to the manufac-
turer’s instructions (Olink Bioscience, Sweden). Briefly, 
myoblasts and mature myotubes were blocked after fixa-
tion in Duolink blocking solution in a humidity chamber 
for 30 min at 37 °C and incubated with primary antibodies: 
polyclonal anti-MVI (1:50) and anti-talin (1:50) in Duolink 
antibody diluent solution for 3 h at 37 °C. Cells were next 
washed twice in a wash buffer for 5 min at room tempera-
ture. For secondary antibodies conjugated with oligonu-
cleotides, PLA probe anti-mouse MINUS and PLA probe 
anti-rabbit PLUS were applied in Duolink antibody diluent 
solution for 1 h at 37 °C and washed twice in a wash buffer 
for 5 min. Duolink assay was further performed strictly 
according to the manufacturer’s instructions. Duolink 
red fluorescence detection kit was used with excitation at 
594 nm and emission at 624 nm. For negative controls, the 
primary antibodies were omitted.
Random motility assay
To perform migration assays, 12,500 of untreated C2C12, 
scrambled or MVI-KD cells were seeded into 24-well cell 
culture plate and grown for 24 h in an appropriate culture 
medium. Then, three different areas per each cell type were 
photographed in DIC Nomarski contrast at 10× magni-
fication every 10 min for 16 h using Retiga 1300 cooled 
CCD camera (QImaging Inc.) and Nikon Diaphot micro-
scope equipped with an environmental chamber. At least 
30 cells of each experimental condition were tracked using 
MetaMorph software. Cell movement between frames was 
assessed by the analysis of the image template shift to the 
position of highest similarity in the following frame. The 
similarity was measured by the cross-correlation function 
value. Statistical analysis was performed using Student’s t 
test.
Results
Myosin VI expression in C2C12 myoblasts
MVI is expressed in undifferentiated (day-0) as well as 
in differentiating (day-3, day-7, and day-10) myoblasts 
(Fig. 1b, c), and its synthesis gradually decreases during 
differentiation (Fig. 1c). In contrast, levels of skeletal mus-
cle myosin heavy chains (fast and slow isoforms) and skel-
etal muscle α-actin increase (Fig. 1c), as expected (Scordi-
lis et al. 1981; Lin and Lin 1986; Hayward et al. 1988). 
Consistently with previous observations, we also observed 
a decrease in β-actin expression (Lin and Lin 1986; Hay-
ward et al. 1988), but we did not notice any substantial dif-
ference in γ-actin expression (Fig. 1c).
Four MVI posttranscriptional splice variants (Fig. 1a) 
can be formed in mammals due to the presence of two 
inserts, large and small, in its C-terminal globular tail 
26 Histochem Cell Biol (2015) 144:21–38
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domain (Aschenbrenner et al. 2003; Au et al. 2007). We 
made an attempt to assess which isoforms are expressed in 
murine myoblasts (Fig. 1d). In undifferentiated myoblasts 
(day-0), the isoforms both with inserts and without the 
inserts are expressed. This pattern changes during differ-
entiation, and in day-10 myotubes, the variants without the 
inserts were the predominant ones.
To examine MVI expression and its cellular distribution, 
we performed immunofluorescence staining of undifferenti-
ated myoblasts (Fig. 1e, αMVI). Endogenous MVI localized 
to puncti distributed within the entire cytoplasm, including 
the leading edge and the perinuclear area. A similar obser-
vation was made for overexpressed GFP-tagged MVI con-
structs encoding all four splice variants with the exception 
of the variant with both inserts (L+S+), which had a higher 
tendency to localize to the perinuclear area (Fig. 1e).
MVI distribution
To define MVI distribution in undifferentiated and differen-
tiating myoblasts, stainings for MVI and markers of vari-
ous cellular compartments were performed (Figs. 2, 3).
In undifferentiated myoblasts, MVI was ubiquitously 
distributed within the cytoplasm, also in areas intensely 
stained for actin filaments (Fig. 2a).
In undifferentiated myoblasts, MVI was also seen next 
to endoplasmic reticulum (ER) and Golgi apparatus cis-
ternae, as visualized by staining with anti-calreticulin and 
anti-GM130 antibodies, respectively (Fig. 2b, c). MVI was 
also seen in the regions adjacent to adhesive structures 
stained with anti-vinculin antibody (Fig. 2d).
To further explore the potential MVI function in myo-
blasts, we transfected the MVI knockdown cells with a con-
struct encoding the human H246R MVI mutant (Fig. 2e). 
This point mutation located within the motor domain was 
previously found to be associated with hypertrophic cardio-
myopathy and predicted to inactivate MVI motor functions 
(Mohiddin et al. 2004); therefore, we used it as a loss-of-
function MVI form with defective motor activity. Our pre-
liminary data indicate, however, that ability of the mutant 
to bind to filamentous actin is not impaired (not shown). 
Expression of the mutant protein caused the formation 
of very large vesicles (with a diameter of about 3–5 μm) 
that localized at the cell periphery (Fig. 2e, arrows). These 
vacuole-like vesicles resembled those found in a patient 
with mutation in dynamin-2 gene (Karolczak et al. 2014), 
indicative of impairment of endocytic vesicle processing. 
Vesicles with similar diameter were also observed in rat 
neonatal cardiomyocytes (Fig. 2f) upon expression of MVI 
mutant protein. Also, overexpression of C2C12 cells with 
the H246R MVI mutant fused with GFP (Fig. 2h) affected 
Golgi apparatus organization as the cisternae stained with 
anti-GM130 antibody were more compact (marked by 
arrowhead) that the ones visible both in untreated cells or 
cells overexpressing wild-type MVI (GFP-MVI, Fig. 2g, 
marked with arrows).
A similar localization pattern of MVI was observed 
for day-3 elongated myoblasts (Fig. 3a, b) and for day-7 
multinuclear myotubes (Fig. 3c–e). MVI was distributed 
throughout the cytoplasm but concentrated at the cell edges 
(Fig. 3a, c, arrows). The concentration of MVI at the tips 
of myotubes was independently confirmed in myotubes 
overexpressing GFP-MVI construct (Fig. 3d). As for myo-
blasts, MVI was also observed in close proximity to the ER 
(Fig. 3b, e, arrows), and its association with this compart-
ment was more prominent in day-7 myotubes. Occasion-
ally, as for muscle (Karolczak et al. 2013), MVI was also 
detected in the nuclei (Fig. 3b, f, arrowheads). Colocaliza-
tion of MVI with the Golgi marker in differentiating myo-
blasts and myotubes was not so evident as for undifferenti-
ated cells (not shown).
Differentiation-dependent increase in colocalization 
of MVI with SERCA-2, the marker of the cardiac ER, 
was also observed for neonatal rat cardiomyocytes (NRC; 
Fig. 4). The two proteins colocalized more clearly in the 
cells cultured for 8 days (Fig. 4b) than in those cultured 
for 2 days (Fig. 4a) after isolation from the heart. MVI was 
also present in the cardiomyocyte nuclei (Fig. 4, arrows).
MVI is enriched in myotube regions stained 
with α‑bungarotoxin
We have previously shown that in skeletal muscle, MVI 
was present in the postsynaptic region of the neuromus-
cular junction (NMJ) in an innervation-dependent man-
ner, indicating its possible involvement in the muscle syn-
apse function/maintenance (Karolczak et al. 2013). To test 
whether MVI could be also involved in the development of 
Fig. 2  MVI localization to different compartments of undifferenti-
ated myoblasts. MVI is visualized in green with anti-MVI antibody 
(a–d) or as GFP-associated fluorescence (e–h), and nuclei were 
stained with DAPI (a–h). a MVI is present in the regions next to 
cortical actin (in red, stained with Alexa Flour 536-conjugated phal-
loidin). b, c MVI is in the close proximity to calreticulin (in red), 
an endoplasmic reticulum marker, and to GM130 (in red), a Golgi 
apparatus marker, respectively. d MVI is present next to vinculin-
containing (in red) adhesive structures. Regions indicated in the 
merged images are shown at higher magnification in the right panel. 
e Overexpression of H246R MVI mutant (in green) myoblasts with 
MVI knockdown; right panel, merged with DAPI staining. f Over-
expression of H246R MVI mutant (in green) in 2-day rat neonatal 
cardiomyocytes. In red, staining for α-actinin, the marker of Z lines. 
Arrows on e and f indicate vacuole-like structures. g, h, Day-0 myo-
blasts overexpressing the GFP-fused wild-type MVI (GFP-MVI) or 
H246R mutant, respectively. Golgi cisternae (in yellow) were stained 
with anti-GM130 monoclonal antibody. Arrows in (g), Golgi cister-
nae in cells overexpressing GFP-MVI, and arrowhead in (h), Golgi 
cisternae in the cell overexpressing the MVI mutant. Bars 20 μm
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the NMJ, we stained C2C12 myoblast-derived myotubes 
cultured on a laminin-coated surface with fluorescently-
labeled α-bungarotoxin (BTX), which binds to acetylcho-
line receptors (AChRs), components of the postsynaptic 
machinery at the NMJ. Myotubes cultured under these con-
ditions were previously shown to form AChR-rich struc-
tures resembling the postsynaptic moiety of the neuromus-
cular junction (Proszynski et al. 2009; Kummer et al. 2004; 
Proszynski and Sanes 2013).
The majority of myotubes developed AChR-rich struc-
tures, which varied in size and organization status (Fig. 5). 
We observed the enrichment of the MVI presence in the 
regions corresponding to the nascent AChR-rich clusters 
(Fig. 5, arrowheads in upper panels). Notably, although 
MVI was present within the clusters, it did not colocal-
ize with the AChR, but was concentrated in AChR-poor 
regions surrounded by or adjacent to the receptors (Fig. 5, 
lower panels, yellow arrowheads).
Fig. 3  MVI localization during myoblast differentiation. MVI in 
day-3 (a, b) and day-7 (c, e) cells is visualized in green with anti-
MVI antibody, and in d as GFP-associated fluorescence. In a as well 
as in (c, d), MVI localizes to actin filaments, especially at myotube 
edges. b, e, MVI is in close proximity to calreticulin (in red), espe-
cially in day-7 myotubes. d Myotube overexpressing GFP-tagged 
full-length MVI (GFP-MVI). GFP-MVI is also enriched at the actin-
rich myotube edge. The far right panels, magnification (as marked 
on the figure) of the regions indicated in the merged panels. Arrows 
point to colocalization of MVI with the examined markers and arrow-
heads to the nuclear MVI presence. Bars 20 μm
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Fig. 4  MVI colocalization with sarcoplasmic reticulum in neona-
tal rat cardiomyocytes. a and b, Localization of MVI (in green) and 
SERCA2 (in red) in day-2 and day-8 cardiomyocytes, respectively. 
Arrows point to the nuclear MVI presence. The far right panels, mag-
nification (as marked in the figure) of the regions indicated in the 
merged panels. Nuclei were stained with TO-PRO®-3 (in blue). Bars 
10 μm
Fig. 5  MVI is present within acetylcholine receptor-rich clusters. a 
upper panels, MVI (in red) is enriched in postsynaptic clusters (in 
green, BTX). In blue, the myotube nuclei stained with DAPI. Mid-
dle panels, ×~2 magnification of regions marked in upper panels and 
bottom panels, ×~1.5 magnification of regions marked in the middle 
panels. Arrowheads point to the regions stained for MVI but lacking 
the BTX-staining. Bars 20 μm
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Effect of MVI knockdown on cell morphology and actin 
cytoskeleton organization
To elucidate the role of MVI in myoblasts (and possibly in 
their differentiation), we created a C2C12 cell line with sta-
ble expression of a MVI shRNA construct. The knockdown 
efficiency was confirmed by immunoblotting (WB) and RT-
PCR (Fig. 6a). We tested three different shRNA sequences 
(not shown) and used the one that gave the strongest reduc-
tion in MVI expression for all subsequent experiments. 
It corresponded to bases 3403–3423 of the mouse Myo6 
sequence, within the MVI tail domain (see Fig. 1a). As 
controls, we used untransfected C2C12 cells and the cells 
transfected with the scrambled sequence. MVI knockdown 
did not significantly affect myoblast growth and prolifera-
tion (Fig. 6b), as compared to control cells.
Morphological analysis revealed that MVI knock-
down cells (MVI-KD) were more oval in comparison 
with untransfected and scrambled myoblasts (Fig. 6c, 
d). Staining for filamentous actin with Alexa-phalloidin 
revealed that MVI-KD cells formed fewer stress fibers 
than control and scrambled cells, suggesting that MVI 
depletion evoked changes in the organization of the 
actin cytoskeleton (Fig. 6e). Since there is no significant 
difference in binding of phalloidin to microfilaments 
formed by the mammalian actin isoforms (Allen et al. 
1996), we performed Western blot analysis (Fig. 6a) 
and immunostaining with antibodies specific for β- and 
Fig. 6  MVI depletion affects cell morphology and actin cytoskeleton 
organization. a Immunoblot analysis (WB) of lysates of untransfected 
myoblasts (C2C12) and myoblasts transfected with a scrambled or 
MVI shRNA sequence (MVI-KD), probed with anti-MVI and anti-β- 
and γ-actin isoforms. Bottom panels RT-PCR analysis of the expres-
sion of MVI and β-actin in the same cell lines. Right panel a quantita-
tive analysis of the MVI content with respect to the GAPDH level. b 
Number of cells per well in each cell line was counted after 24, 48, 
and 72 h. The population doubling time for each culture was found 
not to be statistically significantly different. The values presented as 
means ± SD were obtained from three independent experiments. c 
Assessment of circularity and roundness parameters of the examined 
cell lines. The analysis was performed for about 100 cell for each cell 
line from two independent experiments, d Phase-contrast images of 
untreated (C2C12), scrambled, and MVI-KD myoblasts. e Untreated, 
scrambled, and MVI-KD cells were stained for filamentous actin 
with Alexa Flour 647-conjugated phalloidin as well as with antibod-
ies against γ- and β-actin isoforms. Values in a–c are means ± SD; 
***p < 0.001, as measured by Student’s t test. Bars 20 μm
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γ-actin isoforms (Fig. 6e). It should be emphasized that 
the antibodies recognize both monomeric and filamen-
tous actin. In MVI-KD cells (Fig. 6a), there was a slight 
increase in total β-actin content and a decrease in γ-actin 
content compared to untransfected and scrambled cells. 
Consistent with immunoblot results, fluorescence inten-
sity of γ-actin staining was lower in MVI-KD cells 
(Fig. 6e).
MVI knockdown affects Golgi and ER organization
Since the involvement of MVI in Golgi apparatus mainte-
nance was previously shown for fibroblasts and PC12 neu-
rosecretory cells (Warner et al. 2003; Majewski et al. 2011), 
we checked whether Golgi apparatus organization was also 
impaired in MVI-KD myoblasts. As expected, Golgi mor-
phology in MVI-KD cells was affected: the cisternae were 
Fig. 7  MVI depletion affects Golgi apparatus and endoplasmic 
reticulum. a, b Staining for GM130 and calreticulin in the scrambled 
and MVI-KD cells, respectively. The smaller right panels in (a, b) 
represent ×~2−4 magnification of the regions marked in larger pan-
els. Right panel in (a), assessment of the Golgi area in the scrambled 
and MVI-KD cells. Right panels in (b), assessment of the whole cell 
and the ER areas in the scrambled and MVI-KD cells. Inset quanti-
fication of the ratio of the area of ER to the area of the cell for each 
of the examined cells. The analyses were performed for at least 80 
cells from each examined condition from two independent experi-
ments. Values are means ± SD. ***p < 0.001; *p < 0.01 as meas-
ured by Student’s t test. c Overexpression of GFP-tagged human MVI 
(GFP-MVI, in green) in MVI-KD cell (left cell) restored to some 
extent morphology of the Golgi apparatus (stained in red for GM130, 
marked by arrow). The Golgi apparatus in MVI-KD untransfected 
cell (on the right, marked by arrowhead) remains to be compact. d 
Overexpression of GFP-tagged human MVI (GFP-MVI, in green) 
affects the ER (stained for GRB78, in red) organization of the trans-
fected (an arrow) but not of untransfected (an arrowhead) MVI-KD 
cells. Nuclei are stained with DAPI (in blue). Bars in (a–d), 20 μm
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fragmented, and their area was reduced by about 27 % in 
comparison with scrambled cells (Fig. 7a).
Because MVI was also found next to the ER, especially 
in differentiating cells, we checked whether MVI knock-
down could also affect morphology of this compartment. In 
MVI-KD cells, the ER appeared to be more compact and 
less branched in comparison with scrambled cells (Fig. 7b). 
Moreover, the area covered by the ER in MVI-KD cells 
was about 25 % smaller than in scrambled cells (Fig. 7b).
To assess whether these changes were induced by deple-
tion of MVI, we transfected MVI-KD cells with GFP-
tagged human MVI (GFP-MVI) to rescue the phenotype 
and then stained them with either the Golgi (Fig. 7c) or 
ER (Fig. 7d) marker. Ectopic expression of MVI rescued 
to some extent the phenotype observed in MVI-KD cells. 
Both the Golgi cisternae and the ER in GFP-MVI-express-
ing cells (marked by arrows) more resembled these in 
scrambled cells than those in non-rescued MVI-KD cells.
MVI knockdown affects adhesion complex formation
Changes in actin cytoskeleton organization, especially of 
the cortical region, indicate that MVI depletion could also 
affect cell adhesion. To address this problem, we immu-
nostained MVI-KD and control (scrambled) cells with anti-
vinculin and anti-talin antibodies (Fig. 8a, b, respectively). 
In MVI-KD cells, the vinculin-containing structures were 
smaller, and vinculin immunofluorescence intensity was 
lower (Fig. 8a). Quantitative analysis of vinculin-associated 
pixels confirmed a decrease in the size of focal adhesions in 
MVI-KD cells. Interestingly, the total number of the vincu-
lin-containing adhesive structures was similar in MVI-KD 
and control cells (Fig. 8a).
Talin subcellular distribution was also affected in 
MVI-depleted cells. In untreated C2C12 myoblasts and 
cells transfected with scrambled shRNA, talin immuno-
reactivity was detected in the periphery of cells (Fig. 8b, 
arrows), but such localization was absent in MVI-KD 
cells (Fig. 8b). Importantly, the total expression level of 
talin but not of vinculin was profoundly affected by MVI 
depletion, as revealed by Western blot analysis (Fig. 8c, 
left panel and left graph). Moreover, the analysis of talin 
and vinculin expression during myoblast differentiation 
revealed a substantial decrease in talin but not of vincu-
lin (Fig. 8c, right panel and right graph). Finally, talin 
and MVI are in close proximity to each other, as assessed 
by the PLA assay (Söderberg et al. 2006) performed 
in C2C12 myoblasts (Fig. 8d). This potential interac-
tion is MVI-specific as the number of PLA signals was 
decreased to about 40 % in MVI-depleted myoblasts 
(Fig. 8d, graph). Also, overexpression of GFP-MVI and 
not of GFP alone in MVI-KD cells restored the peripheral 
talin distribution (Fig. 8e, right panels, arrows). Moreo-
ver, close proximity of talin and MVI was maintained also 
within the mature myotube (Fig. 8d, right image). These 
observations are in line with our data obtained by mass 
spectrometry in which we identified talin as a potential 
MVI-binding partner (Karolczak et al. in press). In that 
study, talin was efficiently precipitated with MVI globular 
tail domain from C2C12 cells extract at the day-0, day-
3, and day-7 post-differentiation. These findings further 
imply functional interaction of MVI and talin in adhesive 
structure formation and organization.
MVI knockdown impairs myoblast migration
The observed changes in the cytoskeleton organization 
and adhesive structure formation in MVI-KD cells suggest 
that MVI depletion could also affect myoblast migration. 
Therefore, we assessed myoblast migration by the analy-
sis of random migration by time-lapse microscopy without 
external chemotactic stimuli (Fig. 9). We tracked individual 
cells and measured their migration velocity and mean dis-
tance. MVI-KD moved in a less coordinated manner, i.e., 
they did not continue to move in one direction for a longer 
period of time (Fig. 9a). Moreover, MVI-KD cells migrated 
approximately 25 % slower than cells expressing scrambled 
shRNA and approximately 30 % slower than untransfected 
cells (Fig. 9b). Also, MVI depletion caused a significant 
decrease in the mean distance covered during the experi-
ment when compared with untransfected and scrambled 
cells (Fig. 9b). An inhibitory effect of MVI depletion on 
myoblast migration was also observed in a wound-healing 
assay (not shown).
Fig. 8  MVI in adhesive structures. a Anti-vinculin staining in the 
scrambled and MVI-KD myoblasts. Graphs show the quantification 
of the size (on the left, in pixels) and number (on the right) of vin-
culin-stained focal adhesions. b Anti-talin staining in untransfected 
(C2C12), scrambled, and MVI-KD myoblasts. Arrows point to the 
talin-positive cell edges. c Representative immunoblot of lysates of 
untreated, scrambled, and MVI-KD myoblasts (on the left) as well 
as of untreated myoblasts transferred to differentiating conditions for 
up to 10 days (on the right) probed with anti-vinculin, anti-talin, and 
anti-GAPDH antibodies. Graphs present quantitative analyses of vin-
culin and talin content relative to GAPDH in C2C12, scrambled and 
MVI-KD myoblasts as well as during differentiation (days 0–10); d 
PLA staining (in red) shows proximity of MVI and talin in untreated 
day-0 myoblasts (left panel) and day-10 myotubes (middle panel a 
myotube is contoured in white). In blue, nuclei stained with DAPI. 
Graph (right panel) presents the quantification of the total number of 
PLA signals in the scrambled and MVI-KD cells expressed as per-
cent of control C2C12 myoblasts. At least 20 cells were quantified for 
each condition. The values in a–c are means ± SD. ***p < 0.001. e 
Effects of overexpression of GFP (green, left panels) and GFP-tagged 
human MVI (green, right panels) in MVI-KD cells on localization of 
talin (in white or red). Overexpression of GFP-MVI but not of GFP 
restored a wild-type-like talin staining pattern (arrows). Bars 20 μm
▸
33Histochem Cell Biol (2015) 144:21–38 
1 3
34 Histochem Cell Biol (2015) 144:21–38
1 3
MVI in myotube formation
Since MVI depletion led to disorganization of actin 
cytoskeleton and focal adhesions, and affected the organi-
zation of Golgi and ER, we hypothesized that these effects 
could influence the ability of MVI-depleted cells to form 
differentiated myotubes. To test this hypothesis, we trans-
fected differentiating C2C12 myoblasts with scrambled 
shRNA or a construct targeting MVI and analyzed differen-
tiated myotubes at day 7 after induction of myoblast fusion 
(Fig. 10a). Myotubes depleted in MVI were significantly 
wider than control cells or cells transfected with scrambled 
shRNA (Fig. 10a). To verify the depletion of MVI in these 
experiments, we lysed myotubes at day 7 post-fusion and 
confirmed reduced level of MVI protein using Western blot 
analysis (Fig. 10b).
To quantify the effect of MVI depletion on the tube 
morphology, we analyzed the thickness of myotubes 
from 12 images collected randomly (more than 150 
myotubes for each condition were analyzed in two inde-
pendent experiments). In untreated myotubes and myo-
tubes transfected with scrambled shRNA, most myotubes 
were <35 μm wide with small percent of tubes reaching 
35–50 μm in diameter (Fig. 10c). In contrast, about 20 % 
of MVI-depleted cells were more than 50 μm wide, and 
noteworthy, such wide myotubes were not observed in 
control cells (Fig. 10c). The MVI-KD myotubes were on 
average about twice as wide (54.4 ± 24.6 μm) as those 
Fig. 9  MVI involvement in cell migration. a Migration tracks (reori-
ented to zero in migration traces) of 10 randomly chosen nonprolif-
erating untreated (C2C12), scrambled, or MVI-KD myoblasts. The 
values on x- and y-axes are given in μm. b Cell migration rate and 
mean distance were measured based on the analysis of tracks of 
each 30 untreated C2C12, scrambled, and MVI-KD cells. Values are 
means ± SD. ***p < 0.001
Fig. 10  MVI in myotube formation. a Phase contrast of representa-
tive images of day-7 myotubes. Myotubes formed from untransfected 
myoblasts (C2C12), or from day-1 myoblasts transiently transfected 
with a scrambled construct or MVI shRNA (MVI-KD). Arrows point 
to very wide myotubes. b Representative Western blot analysis of 
MVI level at day 7. c Quantification of the number of wide myo-
tubes in 12 random fields of view presented as % of all myotubes vis-
ible within the respective field of view. The values are means ± SD; 
***p < 0.001. d Day-5 myotubes were transfected with pEGFP con-
structs encoding full-length human MVI fused with GFP (GFP-MVI) 
or the H246R MVI mutant. F-actin (red) and nuclei (blue) were visu-
alized with Alexa Flour 546-conjugated phalloidin and DAPI, respec-
tively. Bars in (a), 100 μm and in (d), 20 μm
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formed by untreated (30.5 ± 8.0 μm) and scrambled 
(26.8 ± 5.4 μm) cells.
To further explore the notion that MVI could play a role 
in myoblast differentiation, we transfected day-5 myo-
blasts with the H246R MVI mutant or the original GFP-
MVI construct as a control. Cells overexpressing the MVI 
mutant for 48 h did not form regular myotubes (Fig. 10d, 
central images). Instead, they became oval with centrally 
located nuclei in a nest-like structure, indicative of impair-
ment in the nuclei positioning and/or cytoskeleton organi-
zation. Occasionally, thin myotube-like forms were spotted 
(Fig. 10d, right image). This is in contrast to control myo-
tubes expressing wild-type MVI, which did not differ from 
their untransfected counterparts (Fig. 10d, left image).
Discussion
In this study, we have addressed the role of MVI in two 
types of myogenic cells: C2C12 myoblasts as well as neo-
natal rat cardiomyocytes. Our data indicate that in myo-
genic cells, MVI may be involved in the organization of 
actin cytoskeleton, Golgi and endoplasmic reticulum, in 
cell migration and adhesion, in the development of the neu-
romuscular junction postsynaptic machinery as well as in 
myotube formation.
Distribution and expression of MVI in myogenic cells
MVI level decreased during myoblast differentiation 
into myotubes, similarly to several other unconventional 
myosins present in myogenic cells (Wells et al. 1997). We 
also observed differences in MVI splice variant expression 
pattern between cells at different stages of differentiation. 
During differentiation, the levels of MVI variants with 
large (LI) and small inserts (SI) decreased, and the predom-
inant variant was the one without inserts, thus resembling 
the pattern characteristic for adult rat skeletal muscles and 
non-polarized cells (Karolczak et al. 2013; Aschenbrenner 
et al. 2003; Au et al. 2007; Dance et al. 2004; Warner et al. 
2003). To our knowledge, this is the first study to address 
MVI variant expression during cell differentiation. Further-
more, as the differentiation was progressing, MVI localiza-
tion was changing from the nearly uniformly cytoplasmic 
to more peripheral. MVI localization was especially promi-
nent at edges of myotubes in vicinity to areas of increased 
F-actin concentration.
MVI in ER and Golgi organization
The observation that MVI is localized next to ER markers, 
especially in myotubes, is in line with our earlier observa-
tion of its presence within the ER of neurosecretory PC12 
cells and sarcoplasmic reticulum (SR) of mature striated 
muscles (Karolczak et al. 2013; Majewski et al. 2010). It 
was previously shown that MVI depletion significantly 
affects Golgi organization (Warner et al. 2003). The cis-
ternae are smaller and more fragmented in fibroblasts from 
mice lacking MVI (Snell’s waltzer model) or PC12 cells 
with MVI knockdown (Warner et al. 2003; Majewski et al. 
2011). Also, our observation that the Golgi cisternae are 
more compact in the cells overexpressing H246R mutant 
indicates that MVI motor activity seems to be important for 
proper organization of this compartment. Further studies on 
the mutant motor activity are yet required.
A decrease in the ER area in MVI-KD myoblasts indi-
cates that MVI could be involved not only in Golgi and but 
also in ER organization. Further supporting this notion, we 
saw differentiation-dependent colocalization of MVI with 
SERCA in rat neonatal cardiomyocytes. We are currently 
working to decipher the precise role of MVI in intracellu-
lar membrane organization by identifying MVI-interacting 
proteins.
MVI involvement in myoblast migration and cell 
adhesion
Our observation that depletion of MVI inhibited myoblast 
migration is in agreement with numerous studies, includ-
ing those on neurosecretory PC12 cells as well as on 
Drosophila border or ovarian cancer cells (Geisbrecht and 
Montell 2002; Yoshida et al. 2004; Majewski et al. 2011). 
The data presented here indicate that this inhibitory effect 
could result from the involvement of MVI in the regulation 
of actin organization and impairment of formation of adhe-
sion structures. We demonstrate that MVI depletion leads 
to a decrease in the size of vinculin-containing adhesion 
complexes, which indicates that MVI could be involved in 
regulation of the size of focal adhesions (Zaidel-Bar et al. 
2003). Also, we observed a possible interaction of MVI 
with talin as well as a correlation between MVI and talin 
expression levels both in undifferentiated myoblasts and 
mature myotubes. These findings are consistent with the 
hypothesis of Maddugoda et al. (2007) that MVI plays a 
critical role in regulation of the morphogenesis of the cell–
substratum (or cell–cell) contacts. Interestingly, interac-
tion of talin with Dictyostelium discoideum myosin VII, 
another unconventional myosin expressed in all Metazoa, 
was reported to play an important role in adhesion complex 
dynamics (Tuxworth et al. 2005; Galdeen et al. 2007).
MVI in neuromuscular junction development
MVI was recently found in the postsynaptic region of the 
neuromuscular junction (NMJ) of rat hindlimb muscles 
and postulated to be involved in junction maintenance and/
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or neuromuscular transmission (Karolczak et al. 2013). Our 
data suggest that MVI might also play a role in the devel-
opment of the postsynaptic part of the junction, since we 
observed enrichment of MVI in the regions corresponding to 
nascent acetylcholine receptor-rich clusters. This hypothesis 
is supported by the presence and engagement of MVI in syn-
aptic transmission at the NMJ of the body wall muscle of the 
Drosophila third instar larvae (Kisiel et al. 2011, 2014). Fur-
ther studies on Snell’s waltzer mice will shed further light on 
the involvement of MVI in NMJ function. Consistently with 
MVI function in synaptic transmission, MVI has been shown 
to be important for brain synapse function (Osterweil et al. 
2005; Yano et al. 2006). Furthermore, depletion of another 
unconventional myosin (VA) caused severe fragmentation 
and size reduction in the NMJ, as well as impairment of ace-
tylcholine receptors in the junction Roder et al. 2008, 2012), 
which further strengthens the idea that unconventional 
myosins may be important for neuromuscular transmission.
MVI in myotube formation
Increasing evidence indicates that multiple cell signaling path-
ways play critical roles in myoblast fusion, including those 
involved in cytoskeleton organization, cell adhesion, and 
migration (Hindi et al. 2013). Our data show that MVI could 
be involved in myoblast differentiation, since MVI deple-
tion in myoblasts caused the formation of significantly wider 
myotubes. Moreover, overexpression of the inactive H246R 
MVI mutant, previously associated with hypertrophic cardio-
myopathy (Mohiddin et al. 2004), resulted in the formation of 
aberrant myotubes with centrally placed nuclei. These effects 
could be due to the above-described effects of MVI depletion 
on myoblast migration and adhesion but also could result from 
a defect in vesicle transport (Fig. 2e, f) or from impairment of 
nuclear positioning. MVI was previously shown to be required 
for targeted membrane transport during cytokinesis, which 
could also affect myotube formation and morphology (Arden 
et al. 2007). While the molecular mechanisms of the involve-
ment of MVI in in vitro myotube formation are unknown, 
it is plausible that the observed effects could to some extent 
explain the hypertrophic cardiomyopathy phenotype reported 
in a patient with the H246R mutant and in MVI knockout 
mice (Mohiddin et al. 2004; Williams et al. 2013).
Conclusions
The data described herein indicate that MVI plays important 
role in myogenic cells, also during their differentiation into 
myotubes. Since MVI is enriched within nascent acetylcho-
line receptor-rich clusters, we postulate that by providing the 
building blocks of postsynaptic machinery and maintaining 
them within the newly formed junction region, this molecular 
motor could participate in the neuromuscular junction develop-
ment. The differentiation-dependent increase in the presence of 
MVI in the ER and changes in the ER organization evoked by 
its depletion imply also a role for MVI in the ER organization/
function. We believe that similarly to observations made for the 
Golgi (Warner et al. 2003; Majewski et al. 2011), this could 
be related to the MVI involvement both in the actin cytoskel-
eton organization and in the vesicle trafficking. We postulate 
that MVI participates not only in a local transport within the 
ER membranous compartment but also in anchoring the ER 
membranes to the adjacent actin cytoskeleton (via its motor 
domain). Observation that MVI-depleted myoblasts have 
impaired migration and adhesion as well as form aberrant myo-
tube indicates that MVI plays important role in myotube for-
mation. Moreover, impairment of myotube formation was also 
observed in cells overexpressing MVI mutant with the motor 
domain. We postulate that interaction of MVI with talin, a cru-
cial element of the adhesion structures, and involvement of 
MVI in the actin cytoskeleton organization are the key features 
that link this motor with myotube formation process. Further 
studies are needed to elucidate the molecular mechanisms of 
possible involvement of MVI in muscle differentiation. Particu-
larly, a thorough examination of skeletal (and cardiac) muscle 
of the Snell’s waltzer mice that is missing to date should yield 
further insight into MVI function in muscle cells. We believe 
it may bring new information on MVI involvement in muscle 
functioning, similarly to the studies on a role for this molecular 
motor in the brain (Osterweil et al. 2005; Yano et al. 2006), kid-
ney (Gotoh et al. 2010), and intestines (Ameen and Apodaca 
2007), despite that no obvious symptoms were present at first.
Acknowledgments We greatly acknowledge invaluable help of Ms. 
Jolanta Nowak from our laboratory in implementing the PLA tech-
nique. Also, we would like to thank Dr. Tama Hasson from Univer-
sity of California, Los Angeles, for sharing with us her MVI plasmids. 
This work was supported by a Grant from Polish National Science 
Center (NCN, 2012/05/E/NZ3/00487) as well as a Grant N303 3593 
35 and the statutory funds for the Nencki Institute from the Ministry 
of Science and Higher Education.
Conflict of interest The authors declare no conflict of interest.
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://crea-
tivecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
Ajima R, Akazawa H, Kodama M, Takeshita F, Otsuka A, Kohno T, 
Komuro I, Ochiya T, Yokota J (2008) Deficiency of Myo18B 
in mice results in embryonic lethality with cardiac myofibrillar 
aberrations. Genes Cells 13:987–999
37Histochem Cell Biol (2015) 144:21–38 
1 3
Allen PG, Shuster CB, Käs J, Chaponnier C, Janmey PA, Herman IM 
(1996) Phalloidin binding and rheological differences among 
actin isoforms. Biochemistry 35:14062–14069
Ameen N, Apodaca G (2007) Defective CFTR Apical Endocytosis 
and Enterocyte Brush Border in Myosin VI-Deficient Mice. Traf-
fic 8:998–1006
Arden SD, Puri C, Au JS, Kendrick-Jones J, Buss F (2007) Myosin VI 
is required for targeted membrane transport during cytokinesis. 
Mol Biol Cell 18:4750–4761
Aschenbrenner L, Lee TT, Hasson T (2003) Myo6 facilitates the 
translocation of endocytic vesicles from cell peripheries. Mol 
Biol Cell 14:2728–2743
Au JS-Y, Puri C, Ihrke G, Kendrick-Jones J, Buss F (2007) Myosin VI 
is required for sorting of AP-1B-dependent cargo to the basolat-
eral domain in polarized MDCK cells. J Cell Biol 177:103–114
Bonn BR, Rudolf A, Hornbruch-Freitag C, Daum G, Kuckwa J, Kastl 
L, Buttgereit D, Renkawitz-Pohl R (2013) Myosin heavy chain-
like localizes at cell contact sites during Drosophila myoblast 
fusion and interacts in vitro with Rolling pebbles 7. Exp Cell Res 
319:402–416
Cao J, Li S, Shao M, Cheng X, Xu Z, Shi D (2014) The PDZ-contain-
ing unconventional myosin XVIIIA regulates embryonic muscle 
integrity in zebrafish. J Genet Genomics 41:417–428
Chibalina MV, Puri C, Kendrick-Jones J, Buss F (2009) Potential roles 
of myosin VI in cell motility. Biochem Soc Trans 37:966–970
Dance AL, Miller M, Seragaki S, Aryal P, White B, Aschenbrenner L, 
Hasson T (2004) Regulation of myosin-VI targeting to endocytic 
compartments. Traffic 5:798–813
Galdeen SA, Stephens S, Thomas DD, Titus MA (2007) Talin influ-
ences the dynamics of the myosin VII-membrane interaction. 
Mol Biol Cell 18:4074–4084
Geisbrecht ER, Montell DJ (2002) Myosin VI is required for E-cad-
herin-mediated border cell migration. Nat Cell Biol 4:616–620
Gotoh N, Yan Q, Du Z, Biemesderfer D, Kashgarian M, Mooseker 
MS, Wang T (2010) Altered renal proximal tubular endocy-
tosis and histology in mice lacking myosin-VI. Cytoskeleton 
67:178–192
Hayward LJ, Zhu YY, Schwartz RJ (1988) Cellular localization of 
muscle and nonmuscle actin mRNAs in chicken primary myo-
genic cultures: the induction of alpha-skeletal actin mRNA is 
regulated independently of alpha-cardiac actin gene expression. 
J Cell Biol 106:2077–2086
Hindi SM, Tajrishi MM, Kumar A (2013) Signaling mechanisms in 
mammalian myoblast fusion. Sci Signal 6:re2
Iskratsch T, Lange S, Dwyer J, Kho AL, dos Remedios C, Ehler E 
(2010) Formin follows function: a muscle-specific isoform of 
FHOD3 is regulated by CK2 phosphorylation and promotes 
myofibril maintenance. J Cell Biol 191:1159–1172
Jung EJ, Liu G, Zhou W, Chen X (2006) Myosin VI is a mediator of 
the p53 cell survival pathway. Mol Cell Biol 26:2175–2186
Karolczak J, Sobczak M, Skowronek K, Re˛dowicz MJ. A kinase 
anchoring protein 9 (AKAP9) is a novel myosin VI binding part-
ner that links myosin VI with the PKA pathway in myogenic 
cells. BioMed Res Internatl, in press
Karolczak J, Sobczak M, Majewski L, Yeghiazaryan M, Jakubiec-
Puka A, Ehler E, Sławin´ska U, Wilczyn´ski GM, Re˛dowicz MJ 
(2013) Myosin VI in skeletal muscle: its localization in the sar-
coplasmic reticulum, neuromuscular junction and muscle nuclei. 
Histochem Cell Biol 139:873–885
Karolczak J, Weis S, Ehler E, Kierdaszuk B, Berdyn´ski M, Zekanow-
ski C, Kamin´ska AM, Re˛dowicz MJ (2014) Myosin VI locali-
zation and expression in striated muscle pathology. Anat Rec 
297:1706–1713
Kisiel M, Majumdar D, Campbell S, Stewart BA (2011) Myosin VI 
contributes to synaptic transmission and development at the 
Drosophila neuromuscular junction. BMC Neurosci 12:65
Kisiel M, McKenzie K, Stewart B (2014) Localization and mobility 
of synaptic vesicles in Myosin VI mutants of Drosophila. PLoS 
ONE 29(7):e102988
Kummer TT, Misgeld T, Lichtman JW, Sanes JR (2004) Nerve-inde-
pendent formation of a topologically complex postsynaptic appa-
ratus. J Cell Biol 164:1077–1087
Lin JJ, Lin JL (1986) Assembly of different isoforms of actin and tropo-
myosin into the skeletal tropomyosin-enriched microfilaments during 
differentiation of muscle cells in vitro. J Cell Biol 103:2173–2183
Maddugoda MP, Crampton MS, Shewan AM, Yap AS (2007) Myo-
sin VI and vinculin cooperate during the morphogenesis of cad-
herin cell–cell contacts in mammalian epithelial cells. J Cell Biol 
178:529–540
Majewski L, Sobczak M, Redowicz MJ (2010) Myosin VI is associ-
ated with secretory granules and is present in nucleus in adrenal 
medulla chromaffin cells. Acta Biochim Polon 57:109–114
Majewski Ł, Sobczak M, Wasik A, Skowronek K, Re˛dowicz MJ 
(2011) Myosin VI in PC12 cells plays important roles in cell 
migration and proliferation but not in catecholamine secretion. J 
Muscle Res Cell Motil 32:291–302
Majewski L, Sobczak M, Havrylov S, Jozwiak J, Redowicz MJ 
(2012) DOCK7: a GEF for Rho-family GTPases and a novel 
myosin VI-binding partner in neuronal PC12 cells. Biochem Cell 
Biol 90:565–574
Mohiddin SA, Ahmed ZM, Griffith AJ, Tripodi D, Friedman TB, 
Fananapazir L, Morell RJ (2004) Novel association of hyper-
trophic cardiomyopathy, sensorineural deafness, and a mutation 
in unconventional myosin VI (MYO6). J Med Genet 41:309–314
Mukherjea M, Ali MY, Kikuti C, Safer D, Yang Z, Sirkia H, Ropars 
V, Houdusse A, Warshaw DM, Sweeney HL (2014) Myosin VI 
must dimerize and deploy its unusual lever arm in order to per-
form its cellular roles. Cell Rep 8:1522–1532
Odronitz F, Kollmar M (2007) Drawing the tree of eukaryotic life 
based on the analysis of 2,269 manually annotated myosins from 
328 species. Genome Biol 8:R196
Osterweil E, Wells DG, Mooseker MS (2005) A role for myosin VI in 
postsynaptic structure and glutamate receptor endocytosis. J Cell 
Biol 168:329–338
Proszynski TJ, Sanes JR (2013) Amotl2 interacts with LL5β, localizes 
to podosomes and regulates postsynaptic differentiation in mus-
cle. J Cell Sci 126:2225–2235
Proszynski TJ, Gingras J, Valdez G, Krzewski K, Sanes JR (2009) 
Podosomes are present in a postsynaptic apparatus and participate 
in its maturation. Proc Natl Acad Sci USA 106:18373–18378
Redowicz MJ (2007) Unconventional myosins in muscle. Eur J Cell 
Biol 86:549–558
Roder IV, Petersen Y, Choi KR, Witzemann V, Hammer JA III, Rudolf 
R (2008) Role of myosin Va in the plasticity of the vertebrate 
neuromuscular junction in vivo. PLoS ONE 3:e3871
Roder IV, Strack S, Reischl M, Dahley O, Khan MM, Kassel O, Zac-
colo M, Rudolf R (2012) Participation of myosin Va and Pka 
type I in the regeneration of neuromuscular junctions. PLoS 
ONE 7:e40860
Salamon M, Millino C, Raffaello A, Mongillo M, Sandri C, Bean C, 
Negrisolo E, Pallavicini A, Valle G, Zaccolo M, Schiaffino S, 
Lanfranchi G (2003) Human MYO18B, a novel unconventional 
myosin heavy chain expressed in striated muscles moves into the 
myonuclei upon differentiation. J Mol Biol 326:137–149
Scordilis SP, Uhlendorf BW, Scarpa S, Cantoni GL, Miles JM, Adel-
stein RS (1981) Changes in myosin and myosin light chain 
kinase during myogenesis. Biochemistry 20:3511–3516
Söderberg O, Gullberg M, Jarvius M, Ridderstråle K, Leuchowius KJ, 
Jarvius J, Wester K, Hydbring P, Bahram F, Larsson LG, Lande-
gren U (2006) Direct observation of individual endogenous 
protein complexes in situ by proximity ligation. Nat Methods 
3:995–1000
38 Histochem Cell Biol (2015) 144:21–38
1 3
Spudich G, Chibalina MV, Au JS, Arden SD, Buss F, Kendrick-
Jones J (2007) Myosin VI targeting to clathrin-coated struc-
tures and dimerization is mediated by binding to Disabled-2 and 
PtdIns(4,5)P2. Nat Cell Biol 9:176–183
Sun Y, Chiu TT, Foley KP, Bilan PJ, Klip A (2014) Myosin Va medi-
ates Rab8A-regulated GLUT4 vesicle exocytosis in insulin-stim-
ulated muscle cells. Mol Biol Cell 25:1159–1170
Sweeney HL, Houdusse A (2007) What can myosin VI do in cells? 
Curr Opin Cell Biol 19:57–66
Sweeney HL, Houdusse A (2010) Myosin VI rewrites the rules for 
myosin motors. Cell 141:573–582
Tumbarello DA, Kendrick-Jones J, Buss F (2013) Myosin VI and its 
cargo adaptors - linking endocytosis and autophagy. J Cell Sci 
126:2561–2570
Tuxworth RI, Stephens S, Ryan ZC, Titus MA (2005) Identification 
of a myosin VII-talin complex. J Biol Chem 280:26557–26564
Vreugde S, Ferrai C, Miluzio A, Hauben E, Marchisio PC, Crippa 
MP, Bussi M, Biffo S (2006) Nuclear myosin VI enhances RNA 
polymerase II-dependent transcription. Mol Cell 23:749–755
Warner CL, Stewart A, Luzio JP, Steel KP, Libby RT, Kendrick-Jones 
J, Buss F (2003) Loss of myosin VI reduces secretion and the 
size of the Golgi in fibroblasts from Snell’s waltzer mice. EMBO 
J 22:569–579
Wells C, Coles D, Entwistle A, Peckham M (1997) Myogenic cells 
express multiple myosin isoforms. J Muscle Res Cell Motil 
18:501–515
Wells AL, Lin AW, Chen LQ, Safer D, Cain SM, Hasson T, Carragher 
BO, Milligan RA, Sweeney HL (1999) Myosin VI is an actin-
based motor that moves backwards. Nature 401:505–508
Williams LH, Miller KA, Dahl HH, Manji SS (2013) Characteriza-
tion of a novel ENU-generated myosin VI mutant mouse strain 
with congenital deafness and vestibular dysfunction. Hear Res 
299:53–62
Yano H, Ninan I, Zhang H, Milner TA, Arancio O, Chao MV (2006) 
BDNF-mediated neurotransmission relies on upon a myosin VI 
motor complex. Nat Neurosci 9:1009–1018
Yoshida H, Cheng W, Hung J, Montell D, Geisbrecht E, Rosen D, 
Liu J, Naora H (2004) Lessons from border cell migration in 
the Drosophila ovary: a role for myosin VI in dissemination of 
human ovarian cancer. Proc Natl Acad Sci USA 101:8144–8149
Zaidel-Bar R, Ballestrem C, Kam Z, Geiger B (2003) Early molecular 
events in the assembly of matrix adhesions at the leading edge of 
migrating cells. J Cell Sci 116:4605–4613
